Effect of corilagin on cerebral ischaemia/reperfusioninduced cerebral injury in a rat model
Purpose: To evaluate the neuroprotective effects of corilagin in cerebral ischaemia-induced cerebral injury in a rat model.
Methods: Cerebral ischaemia was induced by middle cerebral artery occlusion (MCAO). The animals were separated into five groups, including a control group that underwent surgery without inserting a monofilament; MCAO group that received saline; corilagin-treated group (20 mg/kg corilagin, intraperitoneally for 7 days after reperfusion); Tat-Beclin-1-treated group (intraperitoneal injection of 1.5mg/kg of Tat-Beclin-1 on the 3rd and 6th days after MCAO); and corilagin + Tat-Beclin-1-treated group (corilagin for 7 days and Tat-Beclin-1 on the 3rd and 6th days after MCAO). At the end of the treatments, neurological deficit, brain oedema, and volume of infarct were determined in all the animals. Moreover, the level of autophagy in infarcted tissues was evaluated by immunofluorescence, real-time PCR, and western blotting.
Results: There was a significant decrease in neurological deficit, brain oedema, and volume of infarcted tissue in corilagin-treated group when compared with MCAO- and Tat-Beclin-1-treated groups. Treatment with corilagin attenuated the autophagy of astrocytes and neurons in cerebral infarcted tissue, as demonstrated by immunofluorescence, quantitative PCR, and western blotting data.
Conclusion: Corlagin has a protective effect against neuronal damage in cerebral ischaemic rats by decreasing neurological deficit score, infarct volume, and water content of cerebral tissue. Corlagin attenuates autophagy in cerebral tissue, thus protecting cerebral ischaemic rats from neuronal damage.
Keywords: Corilagin, Cerebral ischaemia, Autophagy, Tat-Beclin-1, Neronal damage, Astrocytes, Neurological deficit score, Infarct volume
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.